Andaluri G, Suri RS, Kumar K (2012). Occurrence of estrogen hormones in biosolids, animal manure and mushroom compost. Environ. Monit. Assess. 184(2):1197-1205.
Crossref

Andersson J, Woldegiorgis A, Remberger M, Kaj L, Ekheden Y, Dusan B, Svenson A, Brorström-Lundén E, Dye C, Schlabach M (2006). Results from the Swedish National Screening Programme 2005. Stockholm, Sweden.

Aneck-Hahn NH, Bornman MS, de Jager C (2009). Oestrogenic activity in drinking waters from a rural area in the Waterberg District, Limpopo Province, South Africa. Water SA 35(3):245-251.

Benka-Coker MO, Ojior, OO (1995). Effect of slaughterhouse wastes on the water quality of Ikpoba River, Nigeria. Bioresour Technol. 52(1):5-12.
Crossref

Bergmann A, Fohrmann R, Weber FA (2011). Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln (in German). UBA-Texte 66/2011,Umweltbundesamt,Dessau-Roßlau.

Bound JP, Voulvoulis N (2005). Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ. Health Perspect. 113(12):1705-1711.
Crossref

Boxall A, Rudd M, Brooks B, Caldwell D, Choi K, Hickmann S, Innes E, Ostapyk K, Staveley J, Verslycke T, Ankley G, Beazley K, Belanger S, Berninger J, Carriquiriborde P, Coors A, DeLeo P, Dyer S, Ericson J, Gagné F, Giesy J, Gouin T, Hallstrom L, Karlsson M, Larsson D, Lazorchak J, Mastrocco F, McLaughlin A, McMaster M, Meyerhoff R, Moore R, Parrott J, Snape J, Murray-Smith R, Servos M, Sibley P, Straub J, Szabo N, Topp E, Tetreault G, Vance LT (2012). Pharmaceuticals and personal care products in the environment: What are the big questions? Environ. Health Perspect. pp. 120-129.
Crossref

Carballa M, Omila F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T (2004). Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 38(12):2918-2926.
Crossref

Daughton C (2001). Pharmaceuticals in the environment: Overarching issues and overview. In: Daughton CG, Jones-Lepp TL (eds.). Pharmaceuticals and Personal Care Products in the Environment: Scientific and Regulatory Issues. Symposium Series 791; American Chemical Society. Washington DC USA.

de Jager C, Swemmer A, Aneck-Hahn NH, van Zijl C, van Wyk S, Bornman MS, Barnhoorn I, Jonker M, van Vuren JHJ, Burger AEC (2011). Endocrine Disrupting Chemical (EDC) Activity and Health Effects of Identified Veterinary Growth Stimulants in Surface and Groundwater; WRC Report No. 1686/1/11; Water Research Commission South Africa.

Federal Environment Agency (UBA) (2014). Pharmaceuticals in the environment, global occurrence, effects, and options for action. Report of an International Workshop held April 8th and 9th 2014, International Environment House II, Geneva, Switzerland.

Fick J, Lindberg RH, Kaj L, Brorström-Lundén E (2011). Results from the Swedish National Screening Programme 2010. Stockholm, Sweden, P 56.

Focazio MJ, Kolpin DW, Furlong ET (2004). Occurrence of human pharmaceuticals in water resources of the United States: A review. In: Kummerer, K. (ed.) Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks. 2nd ed. Berlin: Springer.
Crossref

Gardner M, Jones V, Comber S, Scrimshaw MD, Coello‐Garcia T, Cartmell E, Lester J, Ellor B (2013). Performance of UK wastewater treatment works with respect to trace contaminants. Sci. Total Environ. pp. 359-369, 456-457.
Crossref

Hendricks R (2011). Assessment of the biological quality of raw and treated effluents from three sewage treatment plants in the Western Cape, South Africa. Doctoral dissertation. Retrieved from University of the Western Cape electronic thesis and dissertations repository.

Ivashechkin P (2005). Literaturaus ertung zum Vorkommenge fährlicher Stoffeim Abwasser und in Gewässern. Berichtzum Vorhabenim Auftrag des Ministeriums für Umwelt und Naturschutz, Landwirtschaft und Verbraucherschutz Nordrhein-Westfalen.

Jjemba P (2008). Pharmaecology: The occurrence and fate of pharmaceuticals and personal care products. Hoboken NJ: John Wiley and Sons.

Jongh CD, Kooij P, Voogt PD, Laak TT (2012). Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water. Sci. Total Environ. pp. 70-77, 427-428.
Crossref

K'Oreje KO, Demeestere K, De Wispelaere P, Vergeynst L, Dewulf J, Van Langenhove H (2012). From multi-residue screening to target analysis of pharmaceuticals in water: Development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi River Basin, Kenya. Sci. Total Environ. 437:153-164.
Crossref

Kouadio LD, Traore SK, Bekro YA, Véronique M, Dembele A, Mamadou K, Mazellier P, Legube B, Houenou P (2009). Contamination des Eaux de Surface par les Produits Pharmaceutiquesen Zones Urbaines de Côte D'ivoire: Cas du District D'abidjan. Eur. J. Scient. Res. 27(1):140-151.

Miege C, Choubert JM, Ribeiro L, Eusebe M, Coquery M (2009). Fate of pharmaceuticals and personal care products in wastewater treatment plants - Conception of a database and first results. Environ. Pollut. 157:1721-1726.
Crossref

Nakada N, Shinohara H, Murata A, Kiri K, Managakia S, Sato N, Takada H (2007). Removal of selected pharmaceuticals and personal care products [PPCPS] and endocrine-disrupting chemicals [edcs] during sand filtration and ozonation at a municipal sewage treatment plant. Water Res. 41:4373-4382.
Crossref

Nieto A, Borrull F, Marcé RM, Pocurull E (2007). Selective extraction of sulfonamides, macrolides and other pharmaceuticals from sewage sludge by pressurized liquid extraction. J. Chromatogr. A. 1174(1-2):125-131.
Crossref

Okuda T, Yamashita N, Tanaka H, Matsukawa H, Tanabe K (2009). Development of extraction method of pharmaceuticals and their occurrences found in Japanese wastewater treatment plants. Environ. Int. 35(5):815-820.
Crossref

Olayemi AB (1994). Bacteriological water assessment of an urban river in Nigeria. Int. J. Environ. Health Res. 4(3):b156-164.
Crossref

Sanderson H (2011). Presence and risk assessment of pharmaceuticals in surface water and drinking water. Water Sci. Technol. 63:2143-2148.
Crossref

Scheytt T, Mersmann P, Heberer T, Reddersen K (2001). Natural attenuation of pharmaceuticals. In Proceedings of the 2nd International Conference on Pharmaceuticals and Endocrine Disrupting Chemicals in Water, October pp. 9-11.

Senta I, Terzic S, Ahel M (2013). Occurrence and fate of dissolved and particulate antimicrobials in municipal wastewater treatment. Water Res. 47(2):705-714.
Crossref

Servos M, Smith M, McInnis R, Burnison B, Lee B, Seto P, Backus S (2007). The presence of selected pharmaceuticals and the antimicrobial triclosan in drinking water in Ontario, Canada. Water Qual. Res. J. Can. 42:130-137.

Sindiku O, Orata F, Weber R, Osibanjo O (2013). Per- and polyfluoroalkyl substances in selected sewage sludge in Nigeria. Chemosphere 92:329-335.
Crossref

Takada H, Shimizu A, Koike T, Takeshita A, Nakada N, Suzuki S (2012). Ubiquitous distribution of sulfamethoxazole in tropical Asian and African waters. SETAC 6th World Congress/SETAC Europe 22nd Annual Meeting, Berlin, Berlin.

Ternes TA, Herrmann N, Bonerz M, Knacker T, Siegrist H, Joss A (2004). A rapid method to measure the solid-water distribution coefficient (Kd) for pharmaceuticals and musk fragrances in sewage sludge. Water Res. 38(9):4075-4084.
Crossref

Tredoux G, Genthe B, Steyn M, Germanis J (2012). Managed aquifer recharge for potable reuse in Atlantis, South Africa. In: Water reclamation technologies for safe managed aquifer recharge. Eds: Christian Kazner TW, TMelin T, Dillon pp. 121-140.

United Nations Department of Economic and Social Affairs, Population

USGS (2013). Organic W astewater Compounds in W ater and Sediment in and near Restored Wetlands, Great Marsh, Indiana Dunes National Lakeshore, 2009 - 11. pdf. Available at: 

View

WHO (2012). Pharmaceuticals in drinking-water. W orld Health Organization, Geneva 35pp.